查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1631509

全球醫用鞋市場規模、佔有率和趨勢分析報告：按最終用途、分銷管道、地區和細分市場預測（2025-2030）

Medical Footwear Market Size, Share & Trends Analysis Report By End-use (Men, Women), By Distribution Channel (Offline, Online), By Region (North America, Europe, APAC, Central & South America), And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

醫用鞋市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，到2030年，全球醫用鞋市場規模預計將達到182.8億美元，2025年至2030年複合年成長率為11.1%。

足部相關問題、腳踝扭傷、潰瘍、糖尿病、肥胖負擔和足部疼痛病例的增加預計將推動該市場的成長。根據美國足部醫學協會（APMA）統計，2018年，近81%的肥胖者承認因體重超重而出現足部疼痛或多發性足部和踝部疾病。

男性細分市場處於領先地位，佔 2019 年全球銷售額的 57.2%。技術創新和不斷增加的產品推出正在推動對醫用鞋類的需求。例如，2019 年，Footwear Unlimited, Inc. 品牌 Baretraps 推出了採用 Posture+ 技術的舒適鞋子，可幫助穿著者糾正姿勢並減少膝蓋、腳趾和腳踝的壓力和壓力。該鞋具有支撐性後跟杯和內置矯正器具，可減輕足部疼痛。

預計 2020 年至 2027 年，女性用細分市場的複合年成長率將達到 5.9%，是最快的。製造商正在透過推出休閒女性用來擴大產品系列，這推動了該細分市場的成長。例如，2019 年7 月，醫用鞋履品牌Dr.Comfort 宣布推出採用全粒面皮革、減少接縫線、保護性鞋頭和穩定鞋履來幫助提高耐用性、穩定性和支撐性的「The Ruth ”，一款帶有外底、可拆卸外底和耐磨材料的女性用運動休閒鞋。

COVID-19（冠狀病毒）的爆發嚴重影響了包括醫用鞋在內的鞋類產業，由於全球商店關閉、封鎖措施和進出口限制，需求下降。根據亞馬遜公佈的2020年2月中旬至3月中旬的銷售資料，鞋類銷售額平均下降40點。消費者越來越關注自己的消費習慣，傾向於將購買重點放在必需品上，這對市場構成了重大挑戰。

線上分銷管道預計在預測期內成長最快。電子商務通路在製造商中日益普及，以及千禧世代、Z 世代和 X 世代的網路普及率較高，正在推動該通路的銷售。 Amazon、Flipkart、Orthorest 和 Dr. Comfort 等電子商務網站提供折扣、優惠和新產品來吸引消費者。

北美在醫用鞋市場佔據主導地位，2019年佔全球銷售額的33.5%。該區域市場的成長是由於該地區越來越多的人遇到足部相關問題而推動的。根據美國足病醫學協會的報告，50%的美國因設計不良的鞋子或跳躍、跑步、跳舞等高強度活動引起的足部疼痛而限制戶外活動。

預計 2020 年至 2027 年，亞太地區的複合年成長率將達到 6.1%，是最快的。該地區糖尿病患者數量正在增加，預計將推動醫用鞋的需求。此外，中國、印度和日本等國家的人們的健康意識越來越強，願意購買可以緩解慢性足部疼痛的鞋子。

醫療鞋類市場報告亮點

  • 線上銷售管道預計將在 2024 年成為最快的銷售管道，並在整個預測期內保持領先。電子零售商平台上各種品牌醫用鞋的供應量增加、免費送貨和季節性折扣正在推動該細分市場的成長。
  • 由於糖尿病和整形外科疾病等男性足部相關問題的日益普遍，到 2024 年，男性細分市場在醫用鞋行業中佔據最大的收益佔有率。
  • 亞太地區是成長最快的區域市場，2024年至2030年複合年成長率為6.1%。人們對醫用鞋的好處的認知不斷提高，例如增加血液流動、改善流動性和增強足部支撐，預計將推動該區域市場的發展。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章醫療鞋市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關市場展望
  • 產業價值鏈分析
    • 獲利能力分析（產業層面）
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會
    • 市場挑戰
  • 產業分析工具
    • 波特五力分析
  • 打入市場策略

第4章消費行為分析

  • 人口統計分析
  • 消費者趨勢和偏好
  • 影響購買決策的因素
  • 消費品採用
  • 觀察和建議

第5章 醫用鞋市場：通路估算及趨勢分析

  • 醫用鞋市場：按分銷管道分類的要點
  • 分銷通路波動分析及市場佔有率（2024/2030）
  • 依分銷管道分類（2018-2030）
    • 離線
    • 線上

第6章醫用鞋市場：最終用途估計和趨勢分析

  • 醫用鞋市場：按最終用途分類的要點
  • 最終用途變化分析和市場佔有率（2024/2030）
  • 依最終用途分類 (2018-2030)
    • 男性
    • 女士

第7章 醫療鞋市場：區域估計與趨勢分析

  • 醫療鞋類市場：區域展望
  • 區域市場：要點
  • 按地區分類（2018-2030）
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲

第8章醫療鞋市場：競爭分析

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 參與企業概況
  • 財務表現
  • 產品基準
  • 企業熱力圖分析
  • 策略規劃
  • 公司簡介
    • DJO, LLC
    • New Balance
    • Dr. Zen's.
    • Gravity Defyer Corp.
    • Orthofeet Inc
    • Aetrex Inc.
    • DARCO International, Inc.
    • Dr. Foot Inc.
    • Duna
    • Mephisto
Product Code: GVR-4-68038-951-7

Medical Footwear Market Growth & Trends:

The global medical footwear market size is anticipated to reach USD 18.28 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 11.1% from 2025 to 2030. Increasing cases of foot-related issues, ankle sprain, ulcers, diabetes, and strain and foot pain owing to obesity are expected to fuel the growth of this market. According to the American Podiatric Medical Association (APMA), in 2018, close to 81% of obese people accepted that they have witnessed foot pain and multiple foot and ankle conditions due to overweight.

The men segment led the market and accounted for 57.2% share of the global revenue in 2019. Increasing technological innovation and product launches have been driving the demand for medical footwear. For instance, in 2019, Footwear Unlimited, Inc. brand Baretraps introduced comfortable shoes with Posture+ technology that help the wearer to correct the posture and reduce strain and pressure on knees, toes, and ankle. The shoes come with a supportive heel cup and a built-in orthotic that reduces the foot pain.

The women segment is expected to register the fastest CAGR of 5.9% from 2020 to 2027. Manufacturers have been broadening their product portfolio by launching casual looking shoes for women, which is proliferating the segment growth. For instance, in July 2019, Dr. Comfort, a medical footwear brand, launched an athleisure-style shoe, The Ruth in women's category, made of full-grain leather and has reduced seam lines, protective toe box, stable outsoles, removable outsoles, and anti-abrasion material to aid durability, stability, and support.

The COVID-19 (coronavirus) outbreak has severely impacted the footwear industry, including medical footwear, with a reduction in demand owing to store closures, lockdown measures, and restriction in imports and exports at the global level. Sales data reported for Amazon between mid-February and mid-March 2020 showed footwear sales fell by an average of 40 percentage points. Consumers have become more conscious of their spending habits and tend to purchase mostly essential products, which is a major challenge for the market.

The online distribution channel is expected to witness the fastest growth over the forecast period. The rising popularity of e-commerce channels among the manufacturers and high internet penetration among millennials, Gen Z, and Gen X have been driving the sale through this channel. E-commerce websites such as Amazon, Flipkart, Orthorest, and Dr. Comfort offer discounts, deals, and new launches, which attract the consumers and fuel the segment growth.

North America dominated the market for medical footwear and accounted for 33.5% share of the global revenue in 2019. The growth of the regional market is powered by an increasing number of people witnessing foot-related issues in the region. According to a report by the American Podiatric Medical Association, 50% of Americans have limited their outdoor activities due to foot pain because of poor design shoes and high impact activities, such as jumping, running, and dancing.

Asia Pacific is expected to register the fastest CAGR of 6.1% from 2020 to 2027. Increasing cases of diabetes in the region are expected to drive the demand for medical footwear. Moreover, people in the countries, including China, India, and Japan, have become more conscious of their health and are willingly purchasing footwear that can offer relief to chronic foot pain.

Medical Footwear Market Report Highlights:

  • The online distribution channel emerged as the fastest distribution channel in 2024 and is expected to maintain its lead throughout the forecast period. The increasing availability of medical footwear of different brands, free delivery, and seasonal discount on e-retailer platforms are among the major reasons fueling the segment growth
  • The men segment held the largest revenue share in the medical footwear industry in 2024 due to the increasing prevalence of foot-related issues among men, such as diabetes and orthopedic conditions.
  • Asia Pacific is the fastest growing regional market with a CAGR of 6.1% from 2024 to 2030. Growing awareness among people regarding the benefits of medical footwear including increased blood flow, improved mobility, and enhanced foot support is expected to drive the regional market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Medical Footwear Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related Market Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Profit Margin Analysis (Industry-level)
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis Tools
    • 3.4.1. Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Demographic Analysis
  • 4.2. Consumer Trends and Preferences
  • 4.3. Factors Affecting Buying Decision
  • 4.4. Consumer Product Adoption
  • 4.5. Observations & Recommendations

Chapter 5. Medical Footwear Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Medical Footwear Market, by Distribution Channel: Key Takeaways
  • 5.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
  • 5.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
    • 5.3.1. Offline
      • 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 5.3.2. Online
      • 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Medical Footwear Market: End Use Estimates & Trend Analysis

  • 6.1. Medical Footwear Market, by End Use: Key Takeaways
  • 6.2. End Use Movement Analysis & Market Share, 2024 & 2030
  • 6.3. Market Estimates & Forecasts, by End Use, 2018 - 2030 (USD Million)
    • 6.3.1. Men
      • 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 6.3.2. Women
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Medical Footwear Market: Regional Estimates & Trend Analysis

  • 7.1. Medical Footwear Market: Regional Outlook
  • 7.2. Regional Marketplaces: Key Takeaways
  • 7.3. Market Estimates & Forecasts, by region, 2018 - 2030 (USD Million)
    • 7.3.1. North America
      • 7.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.1.2. U.S.
        • 7.3.1.2.1. Key country dynamics
        • 7.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.1.3. Canada
        • 7.3.1.3.1. Key country dynamics
        • 7.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.1.4. Mexico
        • 7.3.1.4.1. Key country dynamics
        • 7.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.2. Europe
      • 7.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.2. UK
        • 7.3.2.2.1. Key country dynamics
        • 7.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.3. Germany
        • 7.3.2.3.1. Key country dynamics
        • 7.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.4. France
        • 7.3.2.4.1. Key country dynamics
        • 7.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.5. Italy
        • 7.3.2.5.1. Key country dynamics
        • 7.3.2.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.2.6. Spain
        • 7.3.2.6.1. Key country dynamics
        • 7.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.3. Asia Pacific
      • 7.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.3.2. China
        • 7.3.3.2.1. Key country dynamics
        • 7.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.3.3. India
        • 7.3.3.3.1. Key country dynamics
        • 7.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.3.4. Japan
        • 7.3.3.4.1. Key country dynamics
        • 7.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.3.5. Australia
        • 7.3.3.5.1. Key country dynamics
        • 7.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.3.6. South Korea
        • 7.3.3.6.1. Key country dynamics
        • 7.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.4. Latin America
      • 7.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.3.4.2. Brazil
        • 7.3.4.2.1. Key country dynamics
        • 7.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.3.5. Middle East & Africa
      • 7.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Medical Footwear Market: Competitive Analysis

  • 8.1. Recent Developments & Impact Analysis, by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Heat Map Analysis
  • 8.7. Strategy Mapping
  • 8.8. Company Profiles
    • 8.8.1. DJO, LLC
      • 8.8.1.1. Company Overview
      • 8.8.1.2. Financial Performance
      • 8.8.1.3. Product Portfolios
      • 8.8.1.4. Strategic Initiatives
    • 8.8.2. New Balance
      • 8.8.2.1. Company Overview
      • 8.8.2.2. Financial Performance
      • 8.8.2.3. Product Portfolios
      • 8.8.2.4. Strategic Initiatives
    • 8.8.3. Dr. Zen's.
      • 8.8.3.1. Company Overview
      • 8.8.3.2. Financial Performance
      • 8.8.3.3. Product Portfolios
      • 8.8.3.4. Strategic Initiatives
    • 8.8.4. Gravity Defyer Corp.
      • 8.8.4.1. Company Overview
      • 8.8.4.2. Financial Performance
      • 8.8.4.3. Product Portfolios
      • 8.8.4.4. Strategic Initiatives
    • 8.8.5. Orthofeet Inc
      • 8.8.5.1. Company Overview
      • 8.8.5.2. Financial Performance
      • 8.8.5.3. Product Portfolios
      • 8.8.5.4. Strategic Initiatives
    • 8.8.6. Aetrex Inc.
      • 8.8.6.1. Company Overview
      • 8.8.6.2. Financial Performance
      • 8.8.6.3. Product Portfolios
      • 8.8.6.4. Strategic Initiatives
    • 8.8.7. DARCO International, Inc.
      • 8.8.7.1. Company Overview
      • 8.8.7.2. Financial Performance
      • 8.8.7.3. Product Portfolios
      • 8.8.7.4. Strategic Initiatives
    • 8.8.8. Dr. Foot Inc.
      • 8.8.8.1. Company Overview
      • 8.8.8.2. Financial Performance
      • 8.8.8.3. Product Portfolios
      • 8.8.8.4. Strategic Initiatives
    • 8.8.9. Duna
      • 8.8.9.1. Company Overview
      • 8.8.9.2. Financial Performance
      • 8.8.9.3. Product Portfolios
      • 8.8.9.4. Strategic Initiatives
    • 8.8.10. Mephisto
      • 8.8.10.1. Company Overview
      • 8.8.10.2. Financial Performance
      • 8.8.10.3. Product Portfolios
      • 8.8.10.4. Strategic Initiatives

List of Tables

  • Table 1 Global medical footwear market: Key market driver analysis
  • Table 2 Global medical footwear market: Key market restraint analysis
  • Table 3 Global medical footwear market estimates & forecast, by distribution channel (USD Million)
  • Table 4 Global medical footwear market estimates & forecast, by end use (USD Million)
  • Table 5 North America medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
  • Table 6 North America medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 7 North America medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8 U.S. macro-economic outlay
  • Table 9 U.S. medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada macro-economic outlay
  • Table 12 Canada medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Mexico macro-economic outlay
  • Table 15 Mexico medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 Europe medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
  • Table 18 Europe medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 UK macro-economic outlay
  • Table 21 UK medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Germany macro-economic outlay
  • Table 24 Germany medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 25 Germany medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 France macro-economic outlay
  • Table 27 France medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 28 France medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 29 Italy macro-economic outlay
  • Table 30 Italy medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 31 Italy medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Spain macro-economic outlay
  • Table 33 Spain medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 34 Spain medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 37 Asia Pacific medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 China macro-economic outlay
  • Table 39 China medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 40 China medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India macro-economic outlay
  • Table 42 India medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 43 India medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 44 Japan macro-economic outlay
  • Table 45 Japan medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 46 Japan medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Australia macro-economic outlay
  • Table 48 Australia medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 49 Australia medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 South Korea macro-economic outlay
  • Table 51 South Korea medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 52 South Korea medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 53 Latin America medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 54 Latin America medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 55 Brazil macro-economic outlay
  • Table 56 Brazil medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 57 Brazil medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa medical footwear market estimates and forecast, by country, 2018 - 2030 (USD Million)
  • Table 59 Middle East & Africa medical footwear market estimates and forecast, by end use, 2018 - 2030 (USD Million)
  • Table 60 Middle East & Africa medical footwear market estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Recent developments & impact analysis, by key market participants
  • Table 62 Company heat map analysis, 2024
  • Table 63 Companies implementing key strategies

List of Figures

  • Fig. 1 Medical footwear market segmentation
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary research approaches
  • Fig. 5 Primary research process
  • Fig. 6 Market snapshot
  • Fig. 7 Segment snapshot
  • Fig. 8 Regional snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Global parent industry and medical footwear size (USD Million)
  • Fig. 11 Global medical footwear size, 2018 to 2030 (USD Million)
  • Fig. 12 Medical footwear market: Penetration & growth prospect mapping
  • Fig. 13 Medical footwear market: Value chain analysis
  • Fig. 14 Medical footwear market: Dynamics
  • Fig. 15 Medical footwear market: Porter's five forces analysis
  • Fig. 16 Medical footwear market estimates & forecast, by distribution channel (USD Million)
  • Fig. 17 Medical footwear market estimates & forecasts for offline, 2018 - 2030 (USD Million)
  • Fig. 18 Medical footwear market estimates & forecasts for online, 2018 - 2030 (USD Million)
  • Fig. 19 Medical footwear market estimates & forecast, by end use (USD Million)
  • Fig. 20 Men medical footwear market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Women medical footwear market estimates & forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Medical footwear market: Regional outlook, 2024 & 2030 (USD Million)
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Canada medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Europe medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Germany medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 30 UK medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 31 France medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Italy medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Spain medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Asia Pacific medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 35 China medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 36 India medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Japan medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Australia medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Latin America medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Brazil medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Middle East & Africa medical footwear market estimates & forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Key company categorization
  • Fig. 44 Strategic framework of medical footwear